A U.S. cancer institute asserted in a Sept. 25complaint that two U.S. researchers are co-inventors of cancer immunotherapy patents that are a result of the collegial exchanges of ideas and draft manuscripts with a Japanese researcher (Dana-Farber Cancer Inst., Inc. v. Ono Pharm. Co.complaint filed).
The complaint—filed by Boston-based Dana-Farber Cancer Institute Inc. in the U.S. District Court for the District of Massachusetts—alleged that Dana-Farber researcher Gordon J. Freeman and Clive R. Wood of the biotech the Genetics Institute, which is based in Cambridge, Mass., made contributions to five patents that show Tasuku Honjo and three colleagues ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.